These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 38512030
1. [leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways]. Fan C, Zhang Y, Yang R, Wu X, Zhou J, Xue J. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):207-214. PubMed ID: 38512030 [Abstract] [Full Text] [Related]
2. Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cells. Fiskus W, Verstovsek S, Manshouri T, Smith JE, Peth K, Abhyankar S, McGuirk J, Bhalla KN. Mol Cancer Ther; 2013 May; 12(5):577-88. PubMed ID: 23445613 [Abstract] [Full Text] [Related]
8. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Manshouri T, Quintás-Cardama A, Nussenzveig RH, Gaikwad A, Estrov Z, Prchal J, Cortes JE, Kantarjian HM, Verstovsek S. Cancer Sci; 2008 Jun; 99(6):1265-73. PubMed ID: 18482053 [Abstract] [Full Text] [Related]
12. Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera. Nagao T, Kurosu T, Umezawa Y, Nogami A, Oshikawa G, Tohda S, Yamamoto M, Miura O. PLoS One; 2014 Jun; 9(1):e84746. PubMed ID: 24404189 [Abstract] [Full Text] [Related]
13. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells. Tong H, Ren Y, Zhang F, Jin J. Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510 [Abstract] [Full Text] [Related]
14. [Naringin inhibits the proliferation and invasion of Eca109 esophageal cancer cells and promotes its apoptosis by blocking JAK/STAT signal pathway]. Yang F, Jiang T, Zhang L, Qi Y, Yang Z. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Dec; 37(12):1085-1091. PubMed ID: 34906296 [Abstract] [Full Text] [Related]
15. Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats. Gao C, Fei X, Wang M, Chen Q, Zhao N. Int Immunopharmacol; 2022 Jun; 107():108610. PubMed ID: 35219163 [Abstract] [Full Text] [Related]
18. LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway. Liu Y, Ma L, Shangguan F, Zhao X, Wang W, Gao Z, Zhou H, Qu G, Huang Y, An J, Xue J, Yang S, Cao Q. Aging (Albany NY); 2020 Sep 05; 12(16):16142-16154. PubMed ID: 32628130 [Abstract] [Full Text] [Related]
19. Rationale for targeting the PI3K/Akt/mTOR pathway in myeloproliferative neoplasms. Bartalucci N, Guglielmelli P, Vannucchi AM. Clin Lymphoma Myeloma Leuk; 2013 Sep 05; 13 Suppl 2():S307-9. PubMed ID: 24290217 [Abstract] [Full Text] [Related]
20. Effects of Ruxolitinib on Immune Checkpoint Molecule Expression in JAK2 V617F-Positive Cells. Fu J, Cheng Z, Zhang L, Wen X, Hao J. Clin Lab; 2024 Oct 01; 70(10):. PubMed ID: 39382932 [Abstract] [Full Text] [Related] Page: [Next] [New Search]